Cited by 811Health Systems, Economic Evaluations, Quality of LifeEconomic and Environmental ValuationPharmaceutical Economics and Policy

The DOI matches its Crossref record; 183 of the 184 references it cites were found in a registry or an index.

Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report

Open access

Ramsey, Scott D., Willke, Richard J., Glick, Henry, Reed, Shelby D., Augustovski, Federico, Jonsson, Bengt, Briggs, Andrew, Sullivan, Sean D.·2015·Value in Health

DOI 10.1016/j.jval.2015.02.001

Open this paper in CoChat — free account

Abstract

Clinical trials evaluating medicines, medical devices, and procedures now commonly assess the economic value of these interventions. The growing number of prospective clinical/economic trials reflects both widespread interest in economic information for new technologies and the regulatory and reimbursement requirements of many countries that now consider evidence of economic value along with clinical efficacy. As decision makers increasingly demand evidence of economic value for health care interventions, conducting high-quality economic analyses alongside clinical studies is desirable because they broaden the scope of information available on a particular intervention, and can efficiently provide timely information with high internal and, when designed and analyzed properly, reasonable external validity. In 2005, ISPOR published the Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force report. ISPOR initiated an update of the report in 2014 to include the methodological developments over the last 9 years. This report provides updated recommendations reflecting advances in several areas related to trial design, selecting data elements, database design and management, analysis, and reporting of results. Task force members note that trials should be designed to evaluate effectiveness (rather than efficacy) when possible, should include clinical outcome measures, and should obtain health resource use and health state utilities directly from study subjects. Collection of economic data should be fully integrated into the study. An incremental analysis should be conducted with an intention-to-treat approach, complemented by relevant subgroup analyses. Uncertainty should be characterized. Articles should adhere to established standards for reporting results of cost-effectiveness analyses. Economic studies alongside trials are complementary to other evaluations (e.g., modeling studies) as information for decision makers who consider evidence of economic value along with clinical efficacy when making resource allocation decisions.

Integrity signals

Registry

Crossref · 10.1016/j.jval.2015.02.001

Cites

183 of 183 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,385
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
World Development indicators
Awais, A. (2015) · Data Archiving and Networked Services (DANS) · doi:10.17632/zcvgc6m58h.1 · Cited by 6,790
Statistical Analysis With Missing Data
Ghosh, S., Little, R. J. A., & Rubin, D. B. (1988) · Technometrics · doi:10.2307/1269814 · Cited by 4,730
Untitled work
(1997) · doi:10.1097/00005650-199711000-00002 · Cited by 4,544

Flagged first, then by citations

Show all 184 references

1 of the 184 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

Sullivan, 2001, Design and analytic considerations in determining the cost-effectiveness of early intervention in asthma from a multinational clinical trial, Control Clin Trials, 22, 420, 10.1016/S0197-2456(01)00137-4 · DOI
Barber, 2000, Analysis of cost data in randomized trials: an application of the nonparametric bootstrap, Stat Med, 19, 3219, 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P · DOI

Sorted by citations

Items 701–800 of 810

Protocol for cost-effectiveness analysis of a randomised trial of mHealth coaching (Bump2Baby and Me) compared with usual care for healthy gestational weight gain and postnatal outcomes in at-risk women and their offspring in the UK, Australia, Ireland and Spain
Pirhonen, L., McAuliffe, F. M., Maindal, H. T., O'Reilly, S. L., Davies, A. K., Burden, C., Skinner, T. C., Vrangbæk, K., & Callander, E. J. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-080823
Cost-Effectiveness of Brief Cognitive Behaviour Therapy
Wang, H. (2024) · CBT: science into practice · doi:10.1007/978-3-031-60746-2_3
Cost-effectiveness analysis of health tapestry, a complex primary care program for older adults: a post-hoc analysis
Tarride, J., Blackhouse, G., Lamarche, L., Forsyth, P., Oliver, D., Carr, T., Howard, M., Thabane, L., Datta, J., Dolovich, L., et al. (2024) · BMC Family Practice · doi:10.1186/s12875-024-02475-5
“The analyses were conducted and reported according to Canadian and international guidelines for economic evaluations [9, 12, 22].”
MethodInfluential
Cost-utility analysis of early reconstruction surgery versus conservative treatment for anterior cruciate ligament injury in a lower-middle income country
Deviandri, R., van der Veen, H. C., Purba, A. K. R., Icanervilia, A. V., Lubis, A. M. T., van den Akker‐Scheek, I., & Postma, M. J. (2024) · BMC Health Services Research · doi:10.1186/s12913-024-11212-8
“However, according to ISPOR guidelines, a long-term perspective is preferred in health economic analyses [20].”
Background
Consideraciones del diseño en investigación para ensayos controlados aleatorios de estimulación de la médula espinal para el dolor: recomendaciones de la iniciativa sobre métodos, medición y evaluación del dolor en ensayos clínicos/Instituto de Neuromodulación/Sociedad Internacional de Neuromodulación
Katz, N. P., Dworkin, R. H., North, R. B., Thomson, S., Eldabe, S. S., Hayek, S. M., Kopell, B. H., Markman, J. D., Rezai, A. R., Taylor, R. S., et al. (2022) · NeuroTarget · doi:10.47924/neurotarget2022124
Cost-effectiveness Analysis Alongside Clinical Trials
Saito, T., Imano, N., Taketomi, N., & Murotani, K. (2024) · Japanese Journal of Biometrics · doi:10.5691/jjb.45.155
Beyond boundaries
Snoek, A. (2024) · doi:10.5463/thesis.960
Cost-Effectiveness of a Tailored Pain Self-Management Intervention Compared With Enhanced Usual Care Among People With HIV and Chronic Pain: An Economic Evaluation
Edwards, K. A., Smith, K. J., Jones, K. F., Bair, M. J., Liebschutz, J. M., McGill, L., Agil, D., Johnson, M. O., Thomas, T., Clay, O. J., et al. (2025) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003671
Cost-effectiveness of support for health professionals to implement physical activity promotion: a protocol for within-trial and modelled economic evaluations of the PROMOTE-PA effectiveness-implementation hybrid trial
Wang, B., Sherrington, C., Cartwright, J., Hassett, L. M., Purcell, K., Savage, R., Tiedemann, A., Chagpar, S., Cheung, D., Noetel, M., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-098452
Clinical and Cost-Effectiveness of an Online Parent-Directed Behavioural Sleep Intervention in addition to Standard Care for Sleep Problems in Children with Epilepsy in the UK: the CASTLE Sleep-E Multicentre, Randomised Controlled TrialPreprint
Gringras, P., Anilkumar, A., Bray, L., Carter, B., Coffey, T. T., Cook, G., Hardy, W., Hughes, D. A., Lalnunhlimi, S., Morris, C., et al. (2025) · medRxiv · doi:10.1101/2025.05.14.25326746
Economic evaluation of a randomised controlled trial - An online bereavement support program for parents following perinatal death
Callander, E. J., Hu, Y., Bull, C. F., Flenady, V., Ellwood, D. A., Lancaster, A., Boyle, F. M., & Loughnan, S. A. (2025) · Women and Birth · doi:10.1016/j.wombi.2025.101933
Siloed thinking: The case for integrating economic and environmental analysis in critical care
Collins, M., Higgins, A. M., McAlister, S., & McGain, F. (2025) · Critical Care and Resuscitation · doi:10.1016/j.ccrj.2025.100111
Surgical quality and health utilization of gastric cancer surgery in China: a post hoc analysis of the Prevalence of Abdominal Complications After Gastroenterological Surgery study
Wu, Z., Gu, T., Wang, X., Wei, T., Shan, F., Li, Z., & Ji, J. (2025) · BMJ Surgery Interventions & Health Technologies · doi:10.1136/bmjsit-2024-000332
“21 22 Comparing surgical quality with other studies We conducted a comprehensive literature search using the PubMed database, employing the keywords “gastrectomy,” “postoperative complication,” “multicenter,” and “national database.””
The effectiveness of combining a home-based Digital motor Telerehabilitation program with conventional therapy in progressive multiple sclerosis: A study protocol for a multicenter, randomized controlled trial
Gandolfi, M., Crestani, M., Perachiotti, G., Salaorni, F., Baroni, A., Gajofatto, A., Orlandi, R., Rimondini, M., Donisi, V., Landi, S., et al. (2025) · Digital Health · doi:10.1177/20552076251323995
“56 The type of economic analysis chosen refer to the health technology assessment (HTA) framework.”
Understanding and Applying Economic Evaluation and Other Analytic Tools
Brownson, R. C., Deshpande, A. D., Gillespie, K. N., & Mazzucca-Ragan, S. (2025) · Oxford University Press eBooks · doi:10.1093/oso/9780197779637.003.0004
The Healthy Homes Study: Protocol for a cluster randomized trial of a place-based smoke-free home intervention in affordable housing
Hawes, M. R., Chakravarty, D., Cheng, J., Handley, M. A., Tsoh, J. Y., Lin, T. K., Hiatt, R. A., & Vijayaraghavan, M. (2025) · PLoS ONE · doi:10.1371/journal.pone.0328786
“We will conduct our analyses aligning with trial-based economic evaluations [76] and present our methodology and assumptions following the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) format for economic evaluations [77].”
Protocol for the Economic Evaluation of the "Healthy for Two/Healthy for You" Pragmatic Lifestyle Intervention in Prenatal Care to Reduce Gestational Weight Gain and Gestational Diabetes Mellitus
Drabo, E. F., McKinney, C. D., Martin, L., Nair, D., Coughlin, J. W., Chen, T., Borahay, M. A., Wang, N., & Bennett, W. L. (2025) · Contemporary Clinical Trials · doi:10.1016/j.cct.2025.108037
Bewertung gesundheitsökonomischer Evaluationen
Müller, D., Kentenich, H., Köberlein–Neu, J., & Stock, S. (2025) · Springer Reference Pflege, Therapie, Gesundheit · doi:10.1007/978-3-662-66798-9_41-1
Economic evaluation of the FIBROWALK multicomponent intervention in online and outdoor formats for fibromyalgia (The On&Out Study)
Auer, W., Serrat, M., Sanabria‐Mazo, J. P., Royuela-Colomer, E., Pérez‐Aranda, A., Ferrés, S., Robles, B., D’Amico, F., Almirall, M., Cardeñosa, E., et al. (2025) · Journal of Pain · doi:10.1016/j.jpain.2025.105515 · Cited by 1
Cost-effectiveness and benefit-cost analyses of promoting handwashing with soap: a systematic reviewPreprint
Ross, I., Bath, D., Wells, J., Dreibelbis, R., Ejemot-Nwadiaro, R. I., Mills, J. E., Greco, G., Pitt, C., & Cumming, O. (2025) · medRxiv · doi:10.1101/2025.10.13.25337661
Cost-utility analysis of a collaborative and stepped care model in patients with mental disorders in German primary care (the COMET study)
Grochtdreis, T., Heddaeus, D., Seeralan, T., Maehder, K., Porzelt, S., Daubmann, A., Pepić, A., Löwe, B., Rosenkranz, M., Schäfer, I., et al. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07428-5
“For economic evaluations, however, it would be ideal to consider the costs and health effects over a long period of time [78].”
Limitations of Disease X vaccine efficacy and safety clinical trialsPreprint
Flaig, J., & Houy, N. (2025) · medRxiv · doi:10.1101/2025.10.11.25337791
Cost Comparison of 2 Different Targets for Glycemic Control in Women With Gestational Diabetes: Evaluation From the TARGET Stepped-Wedge Randomized Trial
Francis, S. E., Lin, L., Edlin, R. P., Gamble, G. D., & Crowther, C. A. (2025) · Value in Health Regional Issues · doi:10.1016/j.vhri.2025.101507
Cost-effectiveness of a UK-based primary healthcare intervention: Improving Medicines use in People with Polypharmacy in Primary Care (IMPPP)Preprint
Gadah-Jeynes, N. S., Annaw, A., Payne, R., McCahon, D., & Round, J. A. (2025) · medRxiv · doi:10.1101/2025.10.23.25338657
Seven-Day vs Four-Day Infusion Set Replacement Interval and Catheter-Related Infections
Elangovan, S., Cai, Y., MITCHELL, B. G., & Graves, N. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.46398
Daoyin Exercise Therapy for the Treatment of Shoulder Pain: Protocol for a Multicenter, Randomized, Single-blinded, Pragmatic Controlled Trial
Lee, J. H., Kim, N.-K., Song, Y.-K., Kim, H., Lee, E. J., Park, S. A., Han, S. E., Kim, M., Keum, D., & Park, S. (2025) · 대한한의학회지 · doi:10.13048/jkm.25059
Clinical Effectiveness and Cost-Effectiveness of Collaborative Treatment With Korean and Western Medicine for Primary Headache Disorders: Protocol for a Multicenter Prospective Observational Study
Kim, J., Yun, J., Kim, L., Acharya, S. R., Han, C., & Kim, N.-K. (2025) · JMIR Research Protocols · doi:10.2196/82819
“The ICER, representing the economic value of collaborative treatment compared with UC, is determined by dividing the incremental cost by the incremental QALYs gained [50,53].”
Economic Evaluation of a Problem-Solving Intervention With Workplace Involvement Among Employees With Common Mental Disorder in Swedish Primary Care: Results From a Cluster-Randomized Controlled Trial
Gyllensten, H., Bergström, G., Freyland, S., & Brämberg, E. B. (2025) · Value in Health Regional Issues · doi:10.1016/j.vhri.2025.101558
Additional file 1 of Systematic review of economic evaluations investigating education, exercise, and dietary weight management to manage hip and knee osteoarthritis: protocol
Mazzei, D. R., Ademola, A., Abbott, J. H., Sajobi, T., Hildebrand, K., & Marshall, D. A. (2020) · Figshare · doi:10.6084/m9.figshare.13059407
Additional file 1 of Protocol for a two-arm pragmatic stepped-wedge hybrid effectiveness-implementation trial evaluating Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship (ENCOMPASS)
Kowalkowski, M. A., Eaton, T. A., McWilliams, A., Tapp, H., Rios, A., Murphy, S., Burns, R., Gutnik, B., O’Hare, K., McCurdy, L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14722101
Additional file 2 of Targeting strategies of antenatal balanced energy and protein supplementation in Addis Ababa, Ethiopia: study protocol for a randomized effectiveness study
Wang, D., Shifraw, T., Costa, J. C., Abdelmenan, S., Tsegaye, S., Berhane, Y. Y., Gulema, H., Berhane, H. Y., Fasil, N., Workneh, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25727887
Additional file 3 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial
Mangin, D. A., Lamarche, L., Agarwal, G., Banh, H. L., Dore Brown, N., Cassels, A., Colwill, K., Dolovich, L., Farrell, B., Garrison, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16880300
Additional file 2 of The economic impact of two diagnostic strategies in the management of restorations in primary teeth: a health economic analysis plan for a trial-based economic evaluation
Freitas, R. D., Moro, B. L. P., Pontes, L. R. A., Maia, H. C. D. M., Pássaro, A. L., Oliveira, R. C., Garbim, J. R., Viganó, M. E. F., Tedesco, T. K., Deery, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17004449
Additional file 2 of Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E. W., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.18318434
Self-citation
Additional file 2 of RISEinFAMILY project: the integration of families at neonatal intensive care units (NICUs) to empower them as primary caregivers: study protocol for a stepped wedge cluster controlled trial
Alferink, M. T., Moreno‐Sanz, B., Cabrera-Lafuente, M., Ergenekon, E., de Haan, T. R., van Kempen, A. A. M. W., Lakhwani, J., Rabe, H., Zaharie, G. C., & Pellicer, A. (2024) · Figshare · doi:10.6084/m9.figshare.26704485
Additional file 1 of Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group
Everest, L., Chen, B. E., Hay, A. E., Cheung, M. C., & Chan, K. K. W. (2024) · Figshare · doi:10.6084/m9.figshare.26608248
Additional file 4 of The economic impact of two diagnostic strategies in the management of restorations in primary teeth: a health economic analysis plan for a trial-based economic evaluation
Freitas, R. D., Moro, B. L. P., Pontes, L. R. A., Maia, H. C. D. M., Pássaro, A. L., Oliveira, R. C., Garbim, J. R., Viganó, M. E. F., Tedesco, T. K., Deery, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17004455
Additional file 1 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial
Mangin, D. A., Lamarche, L., Agarwal, G., Banh, H. L., Dore Brown, N., Cassels, A., Colwill, K., Dolovich, L., Farrell, B., Garrison, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16880291
Additional file 1 of Targeting strategies of antenatal balanced energy and protein supplementation in Addis Ababa, Ethiopia: study protocol for a randomized effectiveness study
Wang, D., Shifraw, T., Costa, J. C., Abdelmenan, S., Tsegaye, S., Berhane, Y. Y., Gulema, H., Berhane, H. Y., Fasil, N., Workneh, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25727846
Additional file 2 of Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E. W., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19076454
Self-citation
Additional file 1 of Cost-effectiveness of prehabilitation prior to elective surgery: a systematic review of economic evaluations
Rombey, T., Eckhardt, H., Kiselev, J., Silzle, J., Mathes, T., & Quentin, W. (2023) · Figshare · doi:10.6084/m9.figshare.23714209
Additional file 1 of Costing malaria interventions from pilots to elimination programmes
Galactionova, K., Velarde, M., Silumbe, K., Miller, J., McDonnell, A., Aguas, R. J., Smith, T. A., & Penny, M. A. (2020) · Figshare · doi:10.6084/m9.figshare.12956005
Additional file 1 of Evaluating a multicomponent program to improve hypertension control in Guatemala: study protocol for an effectiveness-implementation cluster randomized trial
Paniagua-Ávila, A., Fort, M. P., Glasgow, R. E., Gulayin, P., Hernández-Galdamez, D. R., Mansilla, K., Palacios, E., Peralta, A. L., Roche, D., Rubinstein, A., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12456818
Additional file 1 of The effectiveness of a modified Gui Zhi Fu Ling Wan formulation (Gynoclear™) for the treatment of endometriosis: a study protocol for a placebo-controlled, double-blind, randomised controlled trial
Armour, M., Al‐Dabbas, M. A., Ee, C., Smith, C. A., Ussher, J. M., Arentz, S., Lawson, K., & Abbott, J. (2021) · Figshare · doi:10.6084/m9.figshare.14462553
Additional file 3 of The economic impact of two diagnostic strategies in the management of restorations in primary teeth: a health economic analysis plan for a trial-based economic evaluation
Freitas, R. D., Moro, B. L. P., Pontes, L. R. A., Maia, H. C. D. M., Pássaro, A. L., Oliveira, R. C., Garbim, J. R., Viganó, M. E. F., Tedesco, T. K., Deery, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17004452
Additional file 2 of Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E. W., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19075353
Self-citation
Additional file 6 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial
Mangin, D. A., Lamarche, L., Agarwal, G., Banh, H. L., Dore Brown, N., Cassels, A., Colwill, K., Dolovich, L., Farrell, B., Garrison, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16880309
Additional file 2 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial
Mangin, D. A., Lamarche, L., Agarwal, G., Banh, H. L., Dore Brown, N., Cassels, A., Colwill, K., Dolovich, L., Farrell, B., Garrison, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16880297
Additional file 1 of Cost-effectiveness of proton beam therapy vs. conventional radiotherapy for patients with brain tumors in Sweden: results from a non-randomized prospective multicenter study
Sampaio, F., Langegård, U., de Alva, P. M., Flores, S., Nystrand, C., Fransson, P., Ohlsson‐Nevo, E., Kristensen, I. F., Sjövall, K., Feldman, I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27019256
Additional file 1 of The performance of a Bayesian value-based sequential clinical trial design in the presence of an equivocal cost-effectiveness signal: evidence from the HERO trial
Welch, C., Förster, M., Ronaldson, S., Keding, A., Corbacho, B., & Tharmanathan, P. (2024) · Figshare · doi:10.6084/m9.figshare.26751646
Additional file 1 of RISEinFAMILY project: the integration of families at neonatal intensive care units (NICUs) to empower them as primary caregivers: study protocol for a stepped wedge cluster controlled trial
Alferink, M. T., Moreno‐Sanz, B., Cabrera-Lafuente, M., Ergenekon, E., de Haan, T. R., van Kempen, A. A. M. W., Lakhwani, J., Rabe, H., Zaharie, G. C., & Pellicer, A. (2024) · Figshare · doi:10.6084/m9.figshare.26704482
Additional file 1 of Evaluating the cost-effectiveness of [18F]FDG-PET/CT for investigation of persistent or recurrent neutropenic fever in high-risk haematology patients
Tew, M., Douglas, A. P., Szer, J., Bajel, A. R., Harrison, S. J., Tio, S. Y., Worth, L. J., Hicks, R. J., Ritchie, D., Slavin, M. A., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24844667
Additional file 1 of Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E. W., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19075350
Self-citation
Additional file 4 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial
Mangin, D. A., Lamarche, L., Agarwal, G., Banh, H. L., Dore Brown, N., Cassels, A., Colwill, K., Dolovich, L., Farrell, B., Garrison, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16880303
Additional file 5 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial
Mangin, D. A., Lamarche, L., Agarwal, G., Banh, H. L., Dore Brown, N., Cassels, A., Colwill, K., Dolovich, L., Farrell, B., Garrison, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16880306
Additional file 1 of Protocol for the economic evaluation of the InTENSE program for rehabilitation of chronic upper limb spasticity
Milte, R., Ratcliffe, J., Ada, L., English, C., Crotty, M., & Lannin, N. A. (2020) · Figshare · doi:10.6084/m9.figshare.12381569
Additional file 2 of Systematic review of economic evaluations investigating education, exercise, and dietary weight management to manage hip and knee osteoarthritis: protocol
Mazzei, D. R., Ademola, A., Abbott, J. H., Sajobi, T., Hildebrand, K., & Marshall, D. A. (2020) · Figshare · doi:10.6084/m9.figshare.13059410
Additional file 1 of The IMPROVE trial: study protocol for a pragmatic cluster randomised controlled trial to assess the effectiveness of using lay health workers to improve uptake and completion of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease
Gilworth, G., Harris, K., Morgan, T., Ayis, S., Fox-Rushby, J. A., Godfrey, E., Hopkinson, N. S., Lewin, S. A., Lim, K. K., Spinou, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26695110
Additional file 1 of Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E. W., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19076448
Self-citation
Additional file 1 of Cost-effectiveness of prehabilitation of elderly frail or pre-frail patients prior to elective surgery (PRAEP-GO) versus usual care – Protocol for a health economic evaluation alongside a randomized controlled trial
Eckhardt, H., Quentin, W., Silzle, J., Busse, R., & Rombey, T. (2024) · Figshare · doi:10.6084/m9.figshare.25357809
Additional file 1 of Development of a cost of illness inventory questionnaire for children with autism spectrum disorder in South Asia
Chaudhary, D., Bhat, B., Shields, G., Davies, L. M., Green, J., Verghis, T., Roy, R., Kumar, D., Abhilashi, M. K., Vajaratkar, V. P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21069530
Additional file 1 of Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E. W., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.18318431
Self-citation
Additional file 1 of Impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent EQ-5D-5L
Izumi, S., Hagiwara, Y., Matsuyama, Y., Shiroiwa, T., Taira, N., Kawahara, T., Konomura, K., Noto, S., Fukuda, T., & Shimozuma, K. (2024) · Figshare · doi:10.6084/m9.figshare.26561920
Additional file 1 of Six-month cost-effectiveness of adding motivational interviewing or a stratified vocational advice intervention to usual case management for workers with musculoskeletal disorders: the MI-NAV economic evaluation
Tingulstad, A., Maas, E. T., Rysstad, T. L., Øiestad, B. E., Aanesen, F., Pripp, A. H., van Tulder, M. W., & Grotle, M. (2024) · Figshare · doi:10.6084/m9.figshare.26639671
Economic evaluation of behavioral interventions
Jutkowitz, E., Roberts, A. I., & Pizzi, L. T. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21664-0.00035-0
Cost-effectiveness of low-dose amitriptyline for irritable bowel syndrome in primary care
Gkountouras, G., Ford, A. C., Wright-Hughes, A., Alderson, S. L., Ow, P.-L., Ridd, M. J., Foy, R., Bishop, F. L., Chaddock, M., Fernandez, C., et al. (2025) · Frontline Gastroenterology · doi:10.1136/flgastro-2025-103447
“29 In accordance with the statistical analysis plan, 16 imputation models by treat-ment arm used the following variables: minimisation factors (recruitment hub, IBS subtype, baseline HADS-depression score), age, sex, treatment status at 6 months, baseline IBS Severity Scoring System score, 30…”
Can a digital intervention ‘Momentum’ improve social functioning and transdiagnostic symptoms for Australian youth at ultrahigh risk for psychosis? Protocol for a superiority randomised controlled trial comparing treatment as usual with and without Momentum
Mangelsdorf, S. N., Cagliarini, D., Nelson, B., McEnery, C., Whiting, J., Chinnery, G. L., Valentine, L., Lee, Y. Y., Mihalopoulos, C., Liu, V., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-102132
“74 The comparative cost-effectiveness of the Momentum platform (vs TAU) will be summarised using the incremental cost-effectiveness ratio metric (ie, cost per QALY gained).”
Assessing the cost-effectiveness of two psychoeducational interventions for people with cancer and their caregivers: An economic evaluation of the multi-country DIAdIC trial
May, P., Smith, S., Jallow, M., Kalinjuna, T., Vlemnick, A. D., Matthys, O., Goethem, V. V., Grøenvold, M., Guérin, S., Turola, E., et al. (2026) · Contemporary Clinical Trials · doi:10.1016/j.cct.2026.108240
Emerging diseases: when lower vaccine performance in Randomized Clinical Trials means higher economic valuePreprint
Houy, N., & Flaig, J. (2026) · medRxiv · doi:10.64898/2026.01.19.26344387
A psychological talking therapy for suicidality in people experiencing non-affective psychosis: Mechanism and efficacy outcomes of the CARMS (Cognitive AppRoaches to coMbatting Suicidality) randomised controlled trial
Gooding, P. A., Awenat, Y. F., Drake, R., Emsley, R., Jones, S. H., Kapur, N., Lobban, F. A., Peters, S., Pratt, D., Elliott, R. A., et al. (2025) · Efficacy and Mechanism Evaluation · doi:10.3310/gjpg0530
Study protocol for a multiarm, randomized controlled trial to determine the effectiveness of community-based frailty rehabilitation to improve physical function in older adults: The OPTIMAL Fitness Trial
Papaioannou, A., Kennedy, C., Lee, J., Hewston, P. A., McArthur, C., Maharaj, S. S., Adachi, J. D., Boulos, P., Bobba, R. S., Rabinovich, A., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0343338
A Pragmatic Bayesian Adaptive Trial Design Based on the Value of Information: The Value-Driven Adaptive Design
Dymock, M., Marsh, J. I., Jones, M., Heath, A., Murray, K., & Snelling, T. (2026) · Medical Decision Making · doi:10.1177/0272989x261423177
Cost-effectiveness of yoga vs. strengthening exercise for treating knee OA: Evidence from a randomized controlled trial
Jemal, B., Singh, A., Aitken, D. A., Ding, C., Moonaz, S. H., Palmer, A. J., Zhao, T., Drummen, S., Jones, G., Bennell, K. L., et al. (2026) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2026.03.120
Support, Monitoring, and Reminder Technology for Mild Dementia (SMART4MD) for People With Mild Cognitive Impairment and Their Informal Caregivers: Cost-Effectiveness Analysis
Ghani, Z., Jarl, J., Anderberg, P., Berglund, J. S., Aparicio, M. Q., Barnestein‐Fonseca, P., Cellek, S., Mayoral, F., Garolera, M., Guerrero-Pertiñez, G., et al. (2026) · JMIR Human Factors · doi:10.2196/77808
“Moreover, this economic evaluation is based on a pragmatic RCT [54], which improves the generalizability of the findings to older adults who visit primary care facilities seeking assistance with memory-related concerns.”
Qualité de vie relative à la santé chez les patientes atteintes d'un cancer du sein : une revue systématique dans la population moyen-orientale d'une étude prospective libanaise et une analyse du temps jusqu'à détérioration des valeurs d'utilité d'une base de données française
Haidari, R. E. (2021) · doi:10.70675/efb90ba2zf546z4cadz8fb9z8a3097a186c8
A scoping review of decision analytic model-based economic evaluations in neonatal intensive care
King, B. C., Hay, S., & Zupancic, J. A. F. (2026) · Pediatric Research · doi:10.1038/s41390-026-05003-6
Cost-effectiveness of a brief cognitive-behavioral outpatient rehabilitation program for patients with post-COVID-19 condition within a pragmatic randomized controlled trial
Nerli, T. F., Selvakumar, J. P., Heier, I., Johnsen, T. L., Wyller, V. B., & Wisløff, T. F. (2026) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-026-00748-7
“Investigating the cost-effectiveness of interventions targeting non-hospitalized PCC sufferers is crucial to inform decision-makers and should ideally be performed based on efficacy data from an RCT [24].”
Protocol for the health economic evaluation of nature-based social prescribing against loneliness alongside the RECETAS trials
Papon, V., Puntscher, S., Arvandi, M., Jahn, B., Litt, J., Coll‐Planas, L., Masó-Aguado, M., Pitkälä, K. H., Laakkonen, M., Roitto, H., et al. (2026) · BMC Public Health · doi:10.1186/s12889-026-27698-2
“In the presence of significant differences in base-line characteristics between the groups, such as in socio-demographic factors or utility values, adjustment will be made by using multivariable regression-based methods [27, 86].”
Influential
Cognitive Groove community-based rehabilitation for older adults: study protocol for a multisite parallel randomized controlled trial
Papaioannou, A., Ioannidis, G., Kennedy, C., Hladysh, G., Lee, J., Adachi, J. D., Cowan, D., Duarte, D., Hategan, A., Innes, A., et al. (2026) · Trials · doi:10.1186/s13063-026-09782-5
Reducing the impact of diabetic foot ulcers (REDUCE): study protocol for an effectiveness and cost-effectiveness randomised controlled trial with embedded process evaluation
Mitchell, N., Vedhara, K., Ayling, K., Mitchell, A., Sheehan, C., Cullen, K., Hart, R. I., Okanlawon, A. A., Arundel, C., Bradbury, K. J., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-118771
“41 The primary analysis will be a cost-utility analysis presenting an incremental cost per quality-adjusted life year gained over 18 months.”
Response to Ansari et al and Mbmaurya and Gupta
McClinton, S. M., Heiderscheit, B. C., Flynn, T. W., & Pinto, D. (2026) · Physical Therapy · doi:10.1093/ptj/pzag042
Evaluation of technical and economic outcomes of contact force-sensing catheters for pulmonary vein isolation in symptomatic paroxysmal atrial fibrillation in a developing country
Tran, G. S., Van, T. L., Hoang, L. V., Pham, L. T., Dang, H. M., Dao, D. M., Văn, N. T., Nguyen, T. Q., Nguyen, T. T. H., Dang, H. N. N., et al. (2026) · Indian Pacing and Electrophysiology Journal · doi:10.1016/j.ipej.2026.06.002
“Economic value was summarized using the incremental cost-effectiveness ratio (ICER), which represents the additional cost required to achieve one additional patient free from AF recurrence at 3 months with CF-guided ablation compared with the non-CF strategy [18,19].”
Health economic evaluation of an interdisciplinary care pathway for older patients with vertigo, dizziness and balance disorders in primary care (MobilE-PHY2) - a cluster-randomised trial
Zimmer, V., Horstmannshoff, C., Bauer, P., Borchers, P., Scheibe, S., Voigt, K., Müller, M., & Köberlein–Neu, J. (2026) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-026-00779-0
“This health economic evaluation is based on the Consoli-dated Health Economic Evaluation Reporting Standards (CHEERS) [19] in conjunction with the ISPOR-CEA recommendations for conducting cost-effectiveness analysis in the context of clinical trials [20].”
Conduction System Pacing vs Biventricular Pacing in Chronic Heart Failure: Protocol for the Economic Analysis of the PhysioSync-HF Trial
Decker, S. R. D. R., Etges, A. P. B. D. S., Zimerman, A., Alves, F. D., Ternes, C. M. P., Santos, J. S., Zimerman, L. I., Rohde, L. E. P., Forno, A. D., d’Avila, A., et al. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250254i
“15,23,47,48 Model specifications may be adapted based on observed distributions at the end of follow-up.”
Prescription Medication Expenditures and Policy Challenges in the U.S.: A Narrative Review of Economic and Legislative Solutions
Erstad, B. L., & Abraham, I. L. (2025) · Journal of Acute Care Pharmacotherapy · doi:10.67122/001c.144308
Quantifying the Economic Value of Artificial Intelligence–Assisted Diabetic Retinopathy Screening: A Meta-Analysis Using the Incremental Net Benefit Framework
Wei, C., Zhang, L., Chen, C., Le, Y., Feng, Q., Li, Z., & Leng, Z. (2026) · Value in Health · doi:10.1016/j.jval.2026.06.005
CFT+ With a Subsequent Interdisciplinary Pain Management Program (IPMP) If Needed Versus IPMP Alone for Patients With Severe Disabling Chronic LBP: Pragmatic Patient-Blinded RCT With Economic Analysis
Vægter, H. B., Smith, A. J., Johansen, J. V., Stegemejer, I., Fuglsang, K. S., Pedersen, J. F., Sopina, L., Schütze, R., O’Sullivan, P., Kent, P. M., et al. (2026) · Journal of Orthopaedic and Sports Physical Therapy · doi:10.2519/jospt.2026.14238
The Price of Progress: Cost Considerations in Hepatocellular Carcinoma Clinical Trials
Rogers, J. L., Doce, M. M., Fahey, A., Johnson, W. R., & Montenovo, M. I. (2026) · Journal of Surgical Research · doi:10.1016/j.jss.2026.05.079
MDMA-assisted PTSD and Alcohol Therapy Trial (MPATHY): study protocol for a double-blind, randomised, controlled outpatient trial of MDMA-assisted integrated exposure-based therapy for comorbid post-traumatic stress disorder and alcohol use disorder
Morley, K. C., Arunogiri, S., Mills, K. L., Watt, J., Teesson, M., Baillie, A., Lee, Y. Y., Morse, A. R., Back, S. E., Lubman, D. I., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-114896
A Scoping Review of Methods for Extrapolating Costs and Effects in Economic Evaluations of Remote Monitoring
Raunbak, S. M., Christensen, J. J., Weinreich, U. M., Johnsen, S. P., & Udsen, F. W. (2026) · PharmacoEconomics - Open · doi:10.1007/s41669-026-00670-x
“When data are only available for a proportion of the relevant time horizon of the economic evaluation, extrapolation can be applied [23–25 , 30].”
Acne Care Online: protocol for a randomised trial of a digital behaviour change intervention to improve acne-related quality of life amongst 13-25 year olds
Santer, M., Becque, T., Essery, R., Hooper, J., Feuvre, R. L., Sach, T., Henaghan‐Sykes, K., Soulsby, I., Steele, M., Slodkowska‐Barabasz, J., et al. (2026) · NIHR Open Research · doi:10.3310/nihropenres.14302.1
Multicentre prospective randomised controlled non-inferiority trial on the efficacy and safety of minimally invasive SAIF vertebral reconstruction technique versus spinal fixation in unstable osteoporotic vertebral compression fractures: a protocol
Cianfoni, A., Koetsier, E., van Kuijk, S. M. J., Kimman, M., Caterino, F. D., Kaelin, A., Hirsch, J. A., & Willems, P. C. P. H. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-108564
Intrathecal pump refills at home or at the hospital: Protocol for a randomized controlled crossover trial—The IMPROVE study
Hoey, U. V., Winnepenninckx, B., Moens, M., Putman, K., & Goudman, L. (2026) · PLoS ONE · doi:10.1371/journal.pone.0354092
“To address uncertainty in the analysis, a probabilistic sensitivity analysis will be performed [44].”
Characterising the Economic Burden of Functional Dyspepsia: A Cost‐of‐Illness Study of Direct and Indirect Costs
Bosch, D. H. C. A., Essers, B. A. B., Beckers, A. B., Snijkers, J. T. W., Winkens, B., Masclee, A., & Keszthelyi, D. (2026) · United European Gastroenterology Journal · doi:10.1002/ueg2.70257
“The Professional Society for Health Economics and Outcomes Research and the Dutch National Health care institute) [30–32].”
Remote Multicomponent Rehabilitation and Cost-Effectiveness in Survivors of Critical Illness
Zanganeh, M., O'Neill, B. M., Bradley, J. M., Connolly, B. A., Bruce, J., Underwood, M. R., Ratna, M. B., Lall, R., Ji, C., Costley, J., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.28380
Implementing Rehabilitation Robotics in Routine Care: A Mapping Review of Service Delivery Models, Implementation Determinants, Strategies, and Real-World Outcomes
Calabrò, R. S., Calderone, A., Crupi, M. F., Nucifora, M., Lanza, M., & Quartarone, A. (2026) · Healthcare · doi:10.3390/healthcare14162546
The COCCOS study: A protocol for a multicentric quasi-experimental study of a healthcare transition program for young people with chronic conditions
Wilder, L. V., Janssens, N., Hoorenbeeck, K. V., Wyngaert, K. V., Goossens, E., & Smedt, D. D. (2026) · PLoS ONE · doi:10.1371/journal.pone.0353932
“A cost-effectiveness model will be developed following ISPOR guidelines for trial-based economic evaluations [36].”
Effectiveness of psychologically informed physical therapy, tendon-specific exercise program and routine physical therapy in prolonged unilateral shoulder pain and symptom correlations with imaging: a single-center, randomized, parallel-group, three-arm study (RESPECT)
Kemppainen, A., Määttä, J. H., Heikkala, E., Lausmaa, M., Tarnanen, S., Booth, N., Takatalo, J., & Nevalainen, M. T. (2026) · Contemporary Clinical Trials · doi:10.1016/j.cct.2026.108444
A 12‐Month Trial‐Based Economic Evaluation Comparing Positive Parenting Program (Triple P) and Circle of Security Parenting Program (COSP) Versus Treatment as Usual for Families With Young Children (2–6 Years)
Tarride, J., Blackhouse, G., Harvey-Younis, N., Rieder, A. D., Meléndez‐Torres, G. J., Joshi, D., Demy, J., MacMillan, H. L., Attard, C., Jack, S. M., et al. (2026) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.70567
Decompressive craniectomy versus craniotomy for patients undergoing surgical evacuation of an acute subdural hematoma: RESCUE-ASDH RCT and cost effectiveness
Hutchinson, P. J., Mee, H., Adams, H., Mohan, M., Devi, B. I., Uff, C. E. G., Hasan, S., Wilson, M. H., Gupta, D. K., Bulters, D. O., et al. (2025) · Health Technology Assessment · doi:10.3310/gjph0512

Authors: Ramsey, S. D., Willke, R. J., Glick, H., Reed, S. D., Augustovski, F., Jonsson, B., Briggs, A., & Sullivan, S. D.
Affiliations: University of Washington (US)
Pfizer (United States) (US)
University of Pennsylvania (US)
Duke University (US)
Universidad de Buenos Aires (AR)
University of Glasgow (GB)
Corresponding author: Ramsey, Scott D.
ORCID: Ramsey, Scott D.
Willke, Richard J.
Reed, Shelby D.
Augustovski, Federico
Briggs, Andrew
Sullivan, Sean D.
Venue: Value in Health
Publisher: Elsevier BV
Published: 2015-03
Volume: 18
Issue: 2
Pages: 161-172
ISSN: 1098-3015 (ISSN-L)
DOI: 10.1016/j.jval.2015.02.001
OpenAlex: W2139814250
Cited by: 811
References: 184
Citations by year: 2026: 58 · 2025: 75 · 2024: 90 · 2023: 80 · 2022: 100 · 2021: 103 · 2020: 88 · 2019: 65 · 2018: 50 · 2017: 57 · 2016: 37 · 2015: 6
FWCI: 17.59
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 366 d)
Locations: Value in Health (publishedVersion)
PubMed (publishedVersion)
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
Topics: Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Environmental Valuation
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
Keywords: cost-effectiveness analysis, clinical trials, economic evaluation, trial design, health care utilization, health utility, intention-to-treat analysis, subgroup analysis, uncertainty characterization, reporting guidelines, reimbursement decisions, healthcare resource allocation
MeSH terms: Cost-Benefit Analysis, Health Policy, Health Services Research, Humans, Randomized Controlled Trials as Topic, Advisory Committees, Research Report

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks